Results 231 to 240 of about 3,106,622 (403)

Diagnostic Utility of Testing for Novel Murine Autoantibodies for Sjögren's Disease in the Rheumatology Outpatient Setting

open access: yesArthritis Care &Research, Accepted Article.
Objective The goal was to assess the diagnostic performance of three novel autoantibodies (NA) for Sjögren's disease (SjD) by comparing NA prevalence in patients with SjD, other autoimmune rheumatic diseases (ARDs), nonspecific chronic sialadenitis (CS), and controls.
Chadwick R. Johr   +5 more
wiley   +1 more source

Inhaled alpha1-proteinase inhibitor therapy in patients with cystic fibrosis. [PDF]

open access: yesJ Cyst Fibros, 2016
Gaggar A   +7 more
europepmc   +1 more source

Feasibility study of very high aprotinin dosage in polytrauma patients [PDF]

open access: yes, 1987
Clasen, C.   +4 more
core  

Antiviral Cytokines Induce Hepatic Expression of the Granzyme B Inhibitors, Proteinase Inhibitor 9 and Serine Proteinase Inhibitor 61

open access: yesJournal of Immunology, 2004
Mahmoud B. Barrie   +4 more
semanticscholar   +1 more source

Lipid Nanoparticles for the Delivery of CRISPR/Cas9 Machinery to Enable Site‐Specific Integration of CFTR and Mutation‐Agnostic Disease Rescue

open access: yesAdvanced Functional Materials, EarlyView.
Lipid nanoparticles (LNPs) are optimized to co‐deliver Cas9‐encoding messenger RNA (mRNA), a single guide RNA (sgRNA) targeting the endogenous cystic fibrosis transmembrane conductance regulator (CFTR) gene, and homologous linear double‐stranded donor DNA (ldsDNA) templates encoding CFTR.
Ruth A. Foley   +12 more
wiley   +1 more source

System proteinase/inhibitors in the pathogenesis of experimental kidney tuberculosis

open access: gold
D. S. Esmedlyaevа   +4 more
openalex   +1 more source

Home - About - Disclaimer - Privacy